NCCN Oncology Policy Program

The NCCN Oncology Policy Program was initiated in 2009 to allow opportunities for discussion among oncology stakeholders to address relevant health policy concerns. The NCCN Oncology Policy Program has convened Policy Summits in areas such as comparative effectiveness research (CER), risk evaluation and mitigation strategies (REMS), patient advocacy, off-label drug use and compendia, biosimilars and molecular testing.

During 2012, NCCN will continue this initiative with invitation-only summits focused on current policy issues. The first two summits of 2012 will focus on the use of guidelines and pathways and data needs in oncology. For more information, please see below.

For additional information on these and future summits, please see below:

Comparative Effectiveness Research, December 2009
Risk Evaluation and Mitigation Strategies, May 2010
Patient Advocacy, September 2010
Off-Label Drug Use and Compendia, December 2010
Biosimilars, April 2011
Molecular Testing, July 2011
Patient Advocacy, November 2011
Equity in Cancer Care: Pathways, Protocols, and Guidelines, Spring 2012
Data Needs in Oncology – Clinical, Regulatory, Coverage, and Policy Issues, Summer 2012

Please send any comments or questions regarding the NCCN Oncology Policy Program to healthpolicy@nccn.org.

National Comprehensive Cancer Network

Educational Events & Programs

NCCN Oncology Policy Program